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The experimental study of the Borgo 89 Ehrlichia
canis strain had the objective of evaluating the
E. canis-speciﬁc immune response using a dog
IFNc+ ELISpot assay. The Borgo strain, isolated in
Corsica (France), was previously shown to be
highly virulent in dogs in several independent
challenge experiments [1]. A ﬁrst dog was infec-
ted intravenously by extemporaneously thawed
infected dog peripheral blood mononuclear cells
(PBMCs) previously stored in liquid nitrogen.
Infected blood of this dog, which rapidly devel-
oped E. canis-associated clinical signs, was used as
a fresh challenge material to infect two other
healthy dogs. Both dogs were treated by 10 mg ⁄ kg
twice a day of doxycycline for 21 days.
Clinical, haematological and biochemical sur-
veys were carried out during the acute phase of
the disease. Clinical appearance conﬁrmed a high
level of pathogenicity of the Borgo 89 E. canis
strain. Both dogs developed an acute ehrlichiosis,
characterised by a peak of hyperthermia (temper-
ature over 40C), anorexia and pale mucus
between days 11 and 13 post-infection. Haemato-
logical examination showed variable anaemia 3
days after the peak of hyperthermia. For one of
the dogs, the hematocrite decreased to 24%
on day 15 post-infection. Both dogs showed a
leucopoenia at the peak of the disease. This
leucopoenia appeared at the same time as a
thrombocytopenia. Serum protein electrophoresis
revealed a hypoproteinaemia added to a hypoal-
buminaemia at the peak of the disease. Moreover,
electrophoresis showed a small increase of b and c
globulins [2]. Both of the dogs were positive when
tested by indirect immunoﬂuorescence (more
than 1 ⁄ 40) from day 10 post-infection. Overall,
the development of an acute canine ehrlichiosis
was conﬁrmed [3].
Blood was collected at day 11 post-infection
and PBMCs were isolated. Puriﬁed cells were
seeded at a concentration of 5.105 cells ⁄well in an
anti-canine IFN-c antibody pre-coated ELISpot
plate. E. canis antigen, puriﬁed from an E. canis
infected murine monocyte-macrophage cell line
(MDHSP) was added to the cells at four different
doses to allow antigen re-stimulation. As a con-
trol, cells were re-stimulated using antigens
prepared from mock infected MDHSP. After
20 h of incubation at 37C, 10% CO2, the plates
were washed and incubated with a second anti-
canine IFN-c antibody coupled to alkaline phos-
phatase. The enzymatic reaction was detected by
addition of a chromogenic substrate and the
resultant spots were counted using a charge-
coupled device (CCD) camera [4]. The number of
E. canis-speciﬁc IFN-c spots was determined
by subtracting the number of spots obtained
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Fig. 1. Day 11 post-infection Ehrlichia canis-speciﬁc IFNc
T-cell response.
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following re-stimulation with mock infected
MDHSP cells from the number of spots obtained
following re-stimulation with E. canis antigens
from infected MDHSP cells.
For both dogs, the number of non-speciﬁc IFN-c
spots obtained following re-stimulation with anti-
gens prepared from mock infected MDHSP cells
was very low (0–5 spots) at all concentrations
tested (data not shown). In contrast, these two
dogs apparently developed an E. canis-speciﬁc
IFN-c response as shown in Figure 1. Moreover,
we showed that the frequency of detected IFN-c
producing cells was dependent on the antigen
dose, further strengthening the antigen speciﬁcity
of our results.
In conclusion, we conﬁrmed the high pathoge-
nicity of the Borgo 89 strain. Although prelimin-
ary, our results explored for the ﬁrst time the
use of an ELISpot assay for the detection of
E. canis-speciﬁc IFNc producing cells following
antigen re-stimulation. Once validated on a larger
group of infected and control animals, this new
tool will help us to further analyse cellular
immune responses in the context of E. canis
infection in dogs.
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